High expression of fibulin-3 was also linked with poorer survival of mesothelioma among patients with epithelial type (median survival time = 10.5 months), peritoneal mesothelioma patients (median survival time = 8 months), and surgical patients (median survival time = 7.6 months). Here, EFEMP1 is linked to mesothelioma.